Selected research
Industry Research
Famciclovir Industry Research Report 2026
Market perspective
The global Famciclovir market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Famciclovir is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Famciclovir is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Famciclovir is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Famciclovir include Teva, Shandong Luoxin Pharmaceutical Group, Novartis, Mylan, Hainan choitec Pharmaceuticals, Chengdu Diao Pharmaceutical Group, Beijing Jialin Pharmaceutical, Macleods Pharmaceuticals and HISUN, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Famciclovir market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Famciclovir Market by Company
Teva
Shandong Luoxin Pharmaceutical Group
Novartis
Mylan
Hainan choitec Pharmaceuticals
Chengdu Diao Pharmaceutical Group
Beijing Jialin Pharmaceutical
Macleods Pharmaceuticals
HISUN
Hikma
HETERO
Cipla
Aurobindo Pharma
Apotex
Famciclovir Segment by Type
125 mg Tablets
250 mg Tablets
500 mg Tablets
Famciclovir Segment by Application
Cold Sores
Shingles
Genital Herpes
Famciclovir Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Famciclovir market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Famciclovir and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Famciclovir.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Famciclovir manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Famciclovir by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Famciclovir in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 125 mg Tablets
- 250 mg Tablets
- 500 mg Tablets
Applications
- Cold Sores
- Shingles
- Genital Herpes
Companies covered
- Teva
- Shandong Luoxin Pharmaceutical Group
- Novartis
- Mylan
- Hainan choitec Pharmaceuticals
- Chengdu Diao Pharmaceutical Group
- Beijing Jialin Pharmaceutical
- Macleods Pharmaceuticals
- HISUN
- Hikma
- HETERO
- Cipla
- Aurobindo Pharma
- Apotex
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Famciclovir Market Size (2021-2032)
- 2.2.2 Global Famciclovir Sales (2021-2032)
- 2.2.3 Global Famciclovir Market Average Price (2021-2032)
- 2.3 Famciclovir by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 125 mg Tablets
- 2.3.3 250 mg Tablets
- 2.3.4 500 mg Tablets
- 2.4 Famciclovir by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Cold Sores
- 2.4.3 Shingles
- 2.4.4 Genital Herpes
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Famciclovir Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Famciclovir Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global Famciclovir Revenue of Manufacturers (2021-2026)
- 3.4 Global Famciclovir Average Price by Manufacturers (2021-2026)
- 3.5 Global Famciclovir Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Famciclovir, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Famciclovir, Product Type & Application
- 3.8 Global Manufacturers of Famciclovir, Established Date
- 3.9 Global Famciclovir Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva
- 4.1.1 Teva Company Information
- 4.1.2 Teva Business Overview
- 4.1.3 Teva Famciclovir Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Famciclovir Product Portfolio
- 4.1.5 Teva Recent Developments
- 4.2 Shandong Luoxin Pharmaceutical Group
- 4.2.1 Shandong Luoxin Pharmaceutical Group Company Information
- 4.2.2 Shandong Luoxin Pharmaceutical Group Business Overview
- 4.2.3 Shandong Luoxin Pharmaceutical Group Famciclovir Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Shandong Luoxin Pharmaceutical Group Famciclovir Product Portfolio
- 4.2.5 Shandong Luoxin Pharmaceutical Group Recent Developments
- 4.3 Novartis
- 4.3.1 Novartis Company Information
- 4.3.2 Novartis Business Overview
- 4.3.3 Novartis Famciclovir Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Novartis Famciclovir Product Portfolio
- 4.3.5 Novartis Recent Developments
- 4.4 Mylan
- 4.4.1 Mylan Company Information
- 4.4.2 Mylan Business Overview
- 4.4.3 Mylan Famciclovir Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Mylan Famciclovir Product Portfolio
- 4.4.5 Mylan Recent Developments
- 4.5 Hainan choitec Pharmaceuticals
- 4.5.1 Hainan choitec Pharmaceuticals Company Information
- 4.5.2 Hainan choitec Pharmaceuticals Business Overview
- 4.5.3 Hainan choitec Pharmaceuticals Famciclovir Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Hainan choitec Pharmaceuticals Famciclovir Product Portfolio
- 4.5.5 Hainan choitec Pharmaceuticals Recent Developments
- 4.6 Chengdu Diao Pharmaceutical Group
- 4.6.1 Chengdu Diao Pharmaceutical Group Company Information
- 4.6.2 Chengdu Diao Pharmaceutical Group Business Overview
- 4.6.3 Chengdu Diao Pharmaceutical Group Famciclovir Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Chengdu Diao Pharmaceutical Group Famciclovir Product Portfolio
- 4.6.5 Chengdu Diao Pharmaceutical Group Recent Developments
- 4.7 Beijing Jialin Pharmaceutical
- 4.7.1 Beijing Jialin Pharmaceutical Company Information
- 4.7.2 Beijing Jialin Pharmaceutical Business Overview
- 4.7.3 Beijing Jialin Pharmaceutical Famciclovir Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Beijing Jialin Pharmaceutical Famciclovir Product Portfolio
- 4.7.5 Beijing Jialin Pharmaceutical Recent Developments
- 4.8 Macleods Pharmaceuticals
- 4.8.1 Macleods Pharmaceuticals Company Information
- 4.8.2 Macleods Pharmaceuticals Business Overview
- 4.8.3 Macleods Pharmaceuticals Famciclovir Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Macleods Pharmaceuticals Famciclovir Product Portfolio
- 4.8.5 Macleods Pharmaceuticals Recent Developments
- 4.9 HISUN
- 4.9.1 HISUN Company Information
- 4.9.2 HISUN Business Overview
- 4.9.3 HISUN Famciclovir Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 HISUN Famciclovir Product Portfolio
- 4.9.5 HISUN Recent Developments
- 4.10 Hikma
- 4.10.1 Hikma Company Information
- 4.10.2 Hikma Business Overview
- 4.10.3 Hikma Famciclovir Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Hikma Famciclovir Product Portfolio
- 4.10.5 Hikma Recent Developments
- 4.11 HETERO
- 4.11.1 HETERO Company Information
- 4.11.2 HETERO Business Overview
- 4.11.3 HETERO Famciclovir Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 HETERO Famciclovir Product Portfolio
- 4.11.5 HETERO Recent Developments
- 4.12 Cipla
- 4.12.1 Cipla Company Information
- 4.12.2 Cipla Business Overview
- 4.12.3 Cipla Famciclovir Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Cipla Famciclovir Product Portfolio
- 4.12.5 Cipla Recent Developments
- 4.13 Aurobindo Pharma
- 4.13.1 Aurobindo Pharma Company Information
- 4.13.2 Aurobindo Pharma Business Overview
- 4.13.3 Aurobindo Pharma Famciclovir Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Aurobindo Pharma Famciclovir Product Portfolio
- 4.13.5 Aurobindo Pharma Recent Developments
- 4.14 Apotex
- 4.14.1 Apotex Company Information
- 4.14.2 Apotex Business Overview
- 4.14.3 Apotex Famciclovir Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Apotex Famciclovir Product Portfolio
- 4.14.5 Apotex Recent Developments
5 Global Famciclovir Market Scenario by Region
- 5.1 Global Famciclovir Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Famciclovir Sales by Region: 2021-2032
- 5.2.1 Global Famciclovir Sales by Region: 2021-2026
- 5.2.2 Global Famciclovir Sales by Region: 2027-2032
- 5.3 Global Famciclovir Revenue by Region: 2021-2032
- 5.3.1 Global Famciclovir Revenue by Region: 2021-2026
- 5.3.2 Global Famciclovir Revenue by Region: 2027-2032
- 5.4 North America Famciclovir Market Facts & Figures by Country
- 5.4.1 North America Famciclovir Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Famciclovir Sales by Country (2021-2032)
- 5.4.3 North America Famciclovir Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Famciclovir Market Facts & Figures by Country
- 5.5.1 Europe Famciclovir Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Famciclovir Sales by Country (2021-2032)
- 5.5.3 Europe Famciclovir Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Famciclovir Market Facts & Figures by Country
- 5.6.1 Asia Pacific Famciclovir Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Famciclovir Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Famciclovir Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Famciclovir Market Facts & Figures by Country
- 5.7.1 South America Famciclovir Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Famciclovir Sales by Country (2021-2032)
- 5.7.3 South America Famciclovir Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Famciclovir Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Famciclovir Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Famciclovir Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Famciclovir Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Famciclovir Sales by Type (2021-2032)
- 6.1.1 Global Famciclovir Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global Famciclovir Sales Market Share by Type (2021-2032)
- 6.2 Global Famciclovir Revenue by Type (2021-2032)
- 6.2.1 Global Famciclovir Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Famciclovir Revenue Market Share by Type (2021-2032)
- 6.3 Global Famciclovir Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Famciclovir Sales by Application (2021-2032)
- 7.1.1 Global Famciclovir Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global Famciclovir Sales Market Share by Application (2021-2032)
- 7.2 Global Famciclovir Revenue by Application (2021-2032)
- 7.2.1 Global Famciclovir Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Famciclovir Revenue Market Share by Application (2021-2032)
- 7.3 Global Famciclovir Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Famciclovir Value Chain Analysis
- 8.1.1 Famciclovir Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Famciclovir Production Mode & Process
- 8.2 Famciclovir Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Famciclovir Distributors
- 8.2.3 Famciclovir Customers
9 Global Famciclovir Analyzing Market Dynamics
- 9.1 Famciclovir Industry Trends
- 9.2 Famciclovir Industry Drivers
- 9.3 Famciclovir Industry Opportunities and Challenges
- 9.4 Famciclovir Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst